THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Single-Domain Antibodies

Back to Details
This is a "connection" page, showing publications James George has written about Single-Domain Antibodies.
James George
Connection Strength
1.260
Single-Domain Antibodies
  1. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019 07 04; 381(1):92-94.
    View in: PubMed
    Score: 0.667
  2. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer. 2021 05; 68(5):e28949.
    View in: PubMed
    Score: 0.187
  3. TTP: the evolution of clinical practice. Blood. 2021 02 11; 137(6):719-720.
    View in: PubMed
    Score: 0.186
  4. Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab. Am J Hematol. 2020 04; 95(4):E76-E77.
    View in: PubMed
    Score: 0.173
  5. Redefining outcomes in immune TTP: an international working group consensus report. Blood. 2021 04 08; 137(14):1855-1861.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES